The pharmaceutical landscape across the African continent has long been defined by a precarious reliance on external suppliers, but Natco Pharma is currently challenging this status quo with a decisive two hundred and sixty million dollar investment into the South African medical infrastructure.
The intricate network of modern medical advancement relies on a foundational structure that many observers frequently overlook until a global health crisis forces it into the spotlight. As the primary engine for American biomedical science, the National Institutes of Health functions as the
The pharmaceutical industry has long grappled with a massive disconnect between the rapid pace of computational drug discovery and the often-stagnant timelines of physical manufacturing and distribution. In a move designed to bridge this gap, Insilico Medicine and Bora Pharmaceuticals have entered
The landscape of neurological research underwent a fundamental transformation with the publication of the 2024 McDonald Criteria in The Lancet Neurology, setting a new benchmark for diagnostic accuracy and speed. These updated standards replaced the long-standing 2017 framework, introducing a more
The diagnosis of an aggressive glioblastoma in one of the world's leading pathological experts created an unprecedented opportunity to challenge established medical boundaries through self-experimentation. Professor Richard Scolyer, recognized globally for his pioneering work in melanoma, turned
The delicate balance of life within the womb has long been one of the most challenging frontiers for modern medicine, where every intervention must be weighed against the extreme vulnerability of a developing fetus. For decades, clinicians have grappled with the terrifying reality of Twin-Twin
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54
